Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Night Shift Work and Levels of 6-Sulfatoxymelatonin and Cortisol in Men

Dana K. Mirick, Parveen Bhatti, Chu Chen, Frank Nordt, Frank Z. Stanczyk and Scott Davis
Dana K. Mirick
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parveen Bhatti
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chu Chen
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Nordt
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Z. Stanczyk
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Davis
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
1Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center; 2Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 3Rhein Consulting Laboratories, Portland, Oregon; and 4Department of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-12-1377 Published June 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Night shift work is associated with cancer among men, but the biologic mechanism is unclear. We investigated whether male night shift workers showed changes in levels of melatonin and cortisol, potential biomarkers of cancer risk.

Methods: Urine was collected from 185 night shift and 158 day shift-working male healthcare providers, aged 22 to 55 years, throughout work and sleep periods, and assayed for 6-sulfatoxymelatonin and cortisol. Morning serum was collected within 90 minutes of completing the night and assayed for cortisol.

Results: Night shift workers had significantly lower 6-sulfatoxymelatonin levels during daytime sleep, nighttime work, and nighttime sleep on off-nights (57%, 62%, and 40% lower, respectively), relative to the day shift workers during nighttime sleep (P < 0.0001); urinary cortisol in night shift workers was 16% higher during daytime sleep and 13% lower during nighttime sleep on off-nights (P < 0.05). Morning serum cortisol post-work and post-sleep in night shift workers were 24% and 43% lower, respectively, than post-sleep levels among day shift workers (P < 0.0001). Within-subject comparisons among the night shift workers revealed significantly lower melatonin levels and significantly higher urinary cortisol levels during daytime sleep and nighttime work, relative to nighttime sleep (P < 0.01); morning serum cortisol levels post-work were lower than those post-sleep.

Conclusions: Night shift workers have substantially lower 6-sulfatoxymelatonin during night work and daytime sleep, and levels remain low when night shift workers sleep at night. Chronic reduction in melatonin among night shift workers may be an important carcinogenic mechanism. Cortisol secretion patterns may be impacted by night shift work, which could affect cancer risk.

Impact: Shift work could be an important risk factor for many types of cancer. Cancer Epidemiol Biomarkers Prev; 22(6); 1079–87. ©2013 AACR.

  • Received December 20, 2012.
  • Revision received March 11, 2013.
  • Accepted March 15, 2013.
  • ©2013 American Association for Cancer Research.
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (6)
June 2013
Volume 22, Issue 6
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Night Shift Work and Levels of 6-Sulfatoxymelatonin and Cortisol in Men
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Night Shift Work and Levels of 6-Sulfatoxymelatonin and Cortisol in Men
Dana K. Mirick, Parveen Bhatti, Chu Chen, Frank Nordt, Frank Z. Stanczyk and Scott Davis
Cancer Epidemiol Biomarkers Prev June 1 2013 (22) (6) 1079-1087; DOI: 10.1158/1055-9965.EPI-12-1377

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Night Shift Work and Levels of 6-Sulfatoxymelatonin and Cortisol in Men
Dana K. Mirick, Parveen Bhatti, Chu Chen, Frank Nordt, Frank Z. Stanczyk and Scott Davis
Cancer Epidemiol Biomarkers Prev June 1 2013 (22) (6) 1079-1087; DOI: 10.1158/1055-9965.EPI-12-1377
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Statistical Analysis
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement